Go Beyond Diabetes

Every Intake. Earlier Insight. DTC helps capture chronic-risk signals at every intake, support care-gap discovery, and organize signals for provider-directed follow-up from ACO, VBC, and PCP networks.

Screen. Test. Treat.

Diabetes Testing Centers™ (DTC) was founded on the belief that chronic disease should be found long before preventable complications occur. For over a decade, DTC has helped providers uncover chronic health risk through non-invasive assessments that support earlier clinical evaluation. That work has always been about chronic-risk identification—diabetes was simply where those risks most often became apparent first.

Screen using our proprietary intake forms
Test with provider-selected assessments
Treat through provider-directed care

Our intake models captures what patients experience but rarely mention — before they are overlooked, minimized, or left undocumented. It provides no diagnosis, no coding determination, and no treatment recommendation. It organizes what the patient reports into structured chronic-risk signals, with models built from pediatric through geriatric populations.

When a signal warrants a closer look, the provider decides what follows—focused assessment, diagnostic testing, monitoring, referral, or treatment. Every clinical decision remains theirs. DTC does not replace clinical judgment. It strengthens it, by organizing the path from early recognition to informed action.

Most chronic disease does not begin with a diagnosis. It begins with subtle changes in how a person feels, functions, moves, thinks, sleeps, or tolerates an ordinary day. Patients attribute it to aging, stress, or fatigue. Many never mention it at a routine visit unless someone asks in a structured, consistent way.

DTC was founded by former family practice owners who watched preventable chronic disease get recognized only after real damage had been done. Combined with decades of enterprise leadership in diabetes and diagnostics, that experience became a chronic-risk identification platform — designed to help practices see risk sooner without changing how they already deliver care.

Structured intake and focused non-invasive assessments fit inside the existing workflow. No separate clinic. No added staffing. No operational overhaul. With access to a national network of more than 20,000 independent practices, DTC helps providers identify risk earlier and move it toward clinical action faster.

The visit doesn't change. The provider doesn't change. What the practice can see does.

Identify Signals Early

Screen From Anywhere

In-Clinic or Remotely

Important chronic-risk signals often appear early — before they are clearly documented in the chart or raised during the visit. Our intake models supports in-clinic or at-home intake, organizing patient-reported concerns through a proprietary, non-diagnostic framework before the visit, during intake, or through remote outreach. Providers get a consistent way to review potential risk indicators that might otherwise remain undocumented, fragmented, or delayed — and a clearer basis for determining whether further screening, assessment, testing, care-gap review, follow-up, or care-management consideration may be appropriate.

Intake Adult (18-64) serves as the broad front-end screener for the general adult population, organizing patient-reported chronic-risk signals through an age-appropriate framework designed for provider review.

Intake Geriatric (65+) adds an age-focused layer for older adults, where chronic-risk patterns are often more complex, overlapping, and easily missed during routine intake. Its geriatric-risk framework supports provider review, follow-up planning, documentation, and care-gap awareness in the populations where early recognition matters most.

Our proprietary intake models organizes signals across multiple clinical domains aligning to the cardiovascular-kidney-metabolic (CKM) framework recognized by the AHA, ACC, ADA, and ASN and many other chronic conditions.

Find What Others Miss

Direction Before Diagnosis

what others miss

The case for earlier identification is not theoretical—it is measurable and clinically meaningful. By capturing what patients may already be experiencing in a structured way at intake, practices give providers a clearer, better-documented starting point for evaluating whether follow-up assessment, monitoring, referral, or care planning is appropriate.

Chronic damage accumulates long before symptoms become obvious, leaving providers to intervene later, when care is more reactive, costly, and complex. The challenge is that most primary care workflows are not built to consistently capture risk during that earlier window. Patients present with a chief complaint, and providers respond to what is reported.

DTC is designed to close that gap. Its broader health-risk identification model helps identify patient-reported risk signals earlier and organize them for provider review, so clinicians can direct patients toward appropriate evaluation, follow-up, clinical services, or care-management pathways — across fee-for-service, ACO/VBC, and Medicare Advantage workflows.

The practices that benefit most are not adding complexity. They are seeing their existing patients more completely — using a structured pathway to surface risk earlier, document it clearly, and move patients toward timely, provider-directed care.

Turn Intake to Insight

Why Our intake Exists

For more than a decade, DTC has worked with providers on earlier identification of the most common chronic conditions through non-invasive assessment programs. That experience made one thing clear: chronic damage begins long before diagnosis, and the earliest indications are often things patients already notice and can report.

Our proprietary intake models were built from that experience—a patient-administered intake screener that captures structured patient-reported risk signals before the provider encounter and organizes them for review, so providers can determine where focused screening, testing, referral, follow-up, or care-management consideration may be appropriate.

Getting Started Is Simple:

Start with our proprietary intake
Identify structured patient-reported risk signals early and consistently.
Review Patient-Reported Risk Signals
See where patients may benefit from further provider evaluation, and where focused screening, testing, referral, follow-up, or care-management consideration may be appropriate.
Prioritize the Highest-Impact Pathways First
Some patients may require next-step review immediately, while broader clinic trends often become clearer within the first 30 to 90 days of consistent use.

Every Signal Counts

Screen Every Patient

Page updated

Report abuse